Rights and permissions
About this article
Cite this article
The antisense agent ISIS-3521 shows potential in the treatment of non-small-cell lung cancer. Inpharma Wkly. 1265, 8 (2000). https://doi.org/10.2165/00128413-200012650-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012650-00014